Arthur L.L. Adams

Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study

Laetitia E. Lamberts, Maximillian Koch, Johannes S. de Jong et al. · Clinical Cancer Research · 2016 · 267 citations · Full text

Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer

Aram S. A. van Brussel, Arthur L.L. Adams, Sabrina Oliveira et al. · Molecular Imaging and Biology · 2015 · 60 citations · Full text

Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer

Maximilian Koch, Johannes S. de Jong, Jürgen Glatz et al. · Cancer Research · 2016 · 43 citations · Full text

Breast Oncology, Engineering, Pathology +21

Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast

Aram S. A. van Brussel, Arthur L.L. Adams, Jeroen F. Vermeulen et al. · Breast Cancer Research and Treatment · 2013 · 21 citations

Engineering, Carbonic Anhydrase Ix, Health Sciences +10

Near-Infrared Fluorescence Molecular Imaging of Ductal Carcinoma In Situ with CD44v6-Specific Antibodies in Mice: A Preclinical Study

Jeroen F. Vermeulen, Aram S. A. van Brussel, Arthur L.L. Adams et al. · Molecular Imaging and Biology · 2012 · 12 citations · Full text